Enzyme Business â Strategy and activities - Novozymes

More documents

Recommendations

Info

18 8/9/2009NOVOZYMES' CAPITAL MARKETS DAYTransition in Novozymes’ distribution of sales– Not just a question of sales to the bioethanol industryUnique &necessaryenzymesEnzymesfor productspecificclaimsEnzymesforsubstitution• Limitedit • Competing• Competingcompetitiontechnologies• Low degree ofreversibilityTimetechnologies• Correlation withinput prices• Some degree ofreversibility
19 8/9/2009NOVOZYMES' CAPITAL MARKETS DAYSales have been impacted, but earningsremain strong15%10%5%0%-5%-10%-15%-20%Enzyme Business sales H1 2009Enzyme Business gross marginH1 2009DKK growthLCY growthgross margin currency58%56%54%52%50%48%46%44%42%40%H1 2008 H1 2009SOURCE:NOVOZYMES SALES
Page 4 and 5: 4 8/9/2009NOVOZYMES' CAPITAL MARKET
Page 10 and 11: 10 8/9/2009NOVOZYMES' CAPITAL MARKE
Page 14: 14 8/9/2009NOVOZYMES' CAPITAL MARKE
Page 17: 17 8/9/2009NOVOZYMES' CAPITAL MARKE

Enzyme Business â Strategy and activities - Novozymes

Create successful ePaper yourself

Delete template?

Save as template?

Enzyme Business â Strategy and activities - Novozymes